INmune Bio to present Phase 2 imaging data for XPro at AAIC 2026

July 9, 2026 7:00 AM

INmune Bio Inc. (NASDAQ: INMB) announced new imaging data from its Phase 2 study of XPro in patients with early ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found